Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABRAFENIB Cause Aspartate aminotransferase increased? 194 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 194 reports of Aspartate aminotransferase increased have been filed in association with DABRAFENIB (Tafinlar). This represents 1.0% of all adverse event reports for DABRAFENIB.

194
Reports of Aspartate aminotransferase increased with DABRAFENIB
1.0%
of all DABRAFENIB reports
18
Deaths
107
Hospitalizations

How Dangerous Is Aspartate aminotransferase increased From DABRAFENIB?

Of the 194 reports, 18 (9.3%) resulted in death, 107 (55.2%) required hospitalization, and 11 (5.7%) were considered life-threatening.

Is Aspartate aminotransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 194 reports have been filed with the FAERS database.

What Other Side Effects Does DABRAFENIB Cause?

Pyrexia (3,788) Death (2,740) Malignant neoplasm progression (1,667) Fatigue (1,328) Nausea (1,300) Chills (1,235) Rash (1,078) Vomiting (907) Diarrhoea (901) Headache (697)

What Other Drugs Cause Aspartate aminotransferase increased?

METHOTREXATE (1,600) RITUXIMAB (1,351) ADALIMUMAB (1,166) TOCILIZUMAB (975) ETANERCEPT (939) ACETAMINOPHEN (865) LEFLUNOMIDE (863) INFLIXIMAB (823) ABATACEPT (778) NIVOLUMAB (758)

Which DABRAFENIB Alternatives Have Lower Aspartate aminotransferase increased Risk?

DABRAFENIB vs DABRAFENIB\TRAMETINIB DABRAFENIB vs DACARBAZINE DABRAFENIB vs DACLATASVIR DABRAFENIB vs DACLIZUMAB DABRAFENIB vs DACOMITINIB

Related Pages

DABRAFENIB Full Profile All Aspartate aminotransferase increased Reports All Drugs Causing Aspartate aminotransferase increased DABRAFENIB Demographics